Articles

Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group

Division of Pediatric Hematology and Oncology, RWTH-Aachen University, Aachen, Germany;
Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany;
Department of Pediatric Hematology and Oncology, Justus Liebig-University Giessen, Giessen, Germany;
Institute of Pathology, Hematopathology, University Hospital Schleswig Holstein, Kiel, Germany;
Institute of Pathology, Hematopathology, University Hospital Schleswig Holstein, Kiel, Germany;
Pediatric Hematology & Oncology, University Hospital Schleswig Holstein, Campus Kiel, Germany;
Dept. of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria;
Dept. of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria;
Dept. of Pediatric Hematology & Oncology, Children University Hospital Zurich, Zurich, Switzerland;
Medical Biostatistics, Epidemiology & Informatics, Mainz University Medical Center, Germany;
Division of Pediatric Hematology and Oncology, RWTH-Aachen University, Aachen, Germany;
Department of Pediatric Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany;
Department of Pediatric Hematology and Oncology, Justus Liebig-University Giessen, Giessen, Germany;
Dept. of Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany;
DEpt. of Pediatric Hematology & Oncology, University Medical Center Hamburg Eppendorf, Germany
Haematologica Early view Apr 16, 2020 https://doi.org/10.3324/haematol.2019.244780